Ultracentrifugation and concentration of a large volume of serum for HCV RNA during treatment may predict sustained and relapse response in chronic HCV infection

Journal of Medical Virology

Volumn 57, Issue 4, 1999, Pages 351-355

  McHutchison, John G ^a   Blatt, L M ^b   Ponnudurai, R ^a   Goodarzi, K ^a   Russell, J ^b   Conrad, A ^b  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b National Genetics Institute   (United States)

Author keywords

HCV RNA RT PCR; Hepatitis C virus; Response; Treatment; Ultracentrifugation

Indexed keywords

ALANINE AMINOTRANSFERASE; INTERFERON; VIRUS RNA;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD VOLUME; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; MALE; PREDICTION; RELAPSE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ULTRACENTRIFUGATION;

ADULT; FEMALE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RECURRENCE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; TREATMENT OUTCOME; ULTRACENTRIFUGATION;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0033015169     PISSN: 01466615     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9071(199904)57:4<351::AID-JMV4>3.0.CO;2-V     Document Type: Article

References (21)

1. Causse X, Godinot H, Chevalliler M, Chossegros P, Zoulim F, Ouzan D, Heyraud JP, Fontanges T, Albrecht J, Meschievitz C, Trepo C. 1991. Comparison of 1 or 3 MU of interferon alpha-2b and placebo in patients with chronic non-A, non-B hepatitis. Gastroenterology 101:497-502.
2. Chomczynski P, Sacchi N. 1987. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
3. Davis GL. 1994. Prediction of response to interferon treatment of chronic hepatitis C. J Hepatol 21:1-3.
4. Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC, Perrillo RP, Carey W, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, and the Hepatitis Interventional Therapy Group. 1989. Treatment of chronic hepatitis C with recombinant interferon alpha. A multicenter randomized, controlled trial. N Engl J Med 321:1501-1506.
5. Davis G L, Lindsay K, Albrecht J, Bodenheimer HC, Balart LA, Perrillo RP, Dienstag JL, Tamburro C, Schiff ER, Carey E, Payne J, Jacobson IM, Van Thiel DH, Lefkowitch J, Sanghvi B, and the Hepatitis Interventional Therapy Group. 1994. Clinical predictors of response to recombinant interferon - a treatment in patients with chronic non-A non-B hepatitis (hepatitis C). J Viral Hepat 1:1:55-63.
6. Friis RH, Stellers TA. 1996. Epidemiology for public health practice. Gaithersburg, MD: Aspen Publications.
7. Hanley JP, Jarvis LM, Andrews J, Dennis R, Hayes PC, Piris J, Lee R, Simmonds P, Ludlam CA. 1996. Interferon treatment for chronic hepatitis C in hemophiliacs - influence of viral load, genotype, and liver pathology on response. Blood 87:1704-1709.
8. Hino K, Okuda M, Konishi T, Ishioka H, Okita K. 1995. Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy. Dig Dis Sci 40:14-20.
9. Hoofnagle JH, DiBisceglie AM. 1997. The treatment of chronic viral hepatitis. N Engl J Med 336:347-356.
10. Kleter GEM, Brouwer JT, Heijtink RA, Schalm SW, Quint WGV,. 1993. Detection of hepatitis C virus RNA in patients with chronic hepatitis C virus infections during and after therapy with alpha interferon. Antimicrob Agents Chemother 37:595-597.
11. Kohara M, Tanaka T, Tsukiyama-Kohara K, Tanaka S, Mizokami M, Lau JYN, Hattori N. 1995. Hepatitis C virus genotypes 1 and 2 respond to interferon-alpha with different virologic kinetics. J Infect Dis 172:934-938.
12. Marcellin P, Boyer N, Giostra E, Degott C, Courcouce AM, Degos F, Coppere H, Cales P, Couzigou P, Benhamou JP. 1991. Recombinant human α-interferon in patients with chronic non-A and non-B hepatitis: a multicenter randomized controlled trial from France. Hepatology 13:393-397.
13. Martinot-Peignoux M, Narcellin P, Pouteau M, Castelnau C, Boyer N, Poliquin M, Degott C, Descombes I, Le Breton V, Milotova V, Benhamou JP, Erlinger. 1995. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main independent prognostic factors of sustained response to interferon alpha therapy in chronic hepatitis C. Hepatology 22:1050-1056.
14. McHutchison J, Blatt L, Sedghi-Vaziri A, Russell J, Schmid P, Conrad A. 1998. Is there an optimal time to measure quantitative HCV RNA to predict non-response following interferon treatment for chronic HCV infection? J Hepatol 29:362-368.
15. Okamoto H, Okada S, Miyakawa Y, Mayumi M. 1990. The 5′ terminal sequence of the hepatitis C genome. Jpn J Exp Med 60:167-177.
16. Orito E, Mizokami M, Suzuki K, Ohba K, Ohno T, Mori M, Hayashi K, Kato K, Iino S, Lau JY. 1995. Loss of serum HCV RNA at week 4 of interferon alpha therapy is associated with more favorable long-term response in patients with chronic hepatitis C. J Med Virol 46:109-115.
17. Poynard T, Bedossa P, Chevallier M, Mathurin P, Lemmonier C, Trepo C, Couzigou P, Payen JL, Sajus M, Costa JM. 1995. A comparison of three interferon alpha-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group. N Engl J Med 332:1457-1462.
18. Poynard T, Leroy V, Cohard M, Thevenot T, Mathurin P, Opolon P, Zarski JP. 1996. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 24:778-789.
19. Serfaty L, Giral P, Loria A, Andreani T, Legendre C, Poupon R. 1994. Factors predictive of the response to interferon in patients with chronic hepatitis C. J Hepatol 21:12-17.
20. Stuyver I, Rossau R, Wyseur A, Duhamel M, Vanderborght B, Van Heuverswyn H, Maertens G. 1993. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74:1093-1102.
21. Tong MJ, Blatt LM, McHutchison JG, Hor Y, Co RL, Conrad A. 1997. Early prediction of response to interferon alpha 2b therapy in chronic hepatitis C patients using viral and biochemical characteristics: a comparison. Hepatology 26:1640-1645.